Mckesson Corp
NYSE:MCK

Watchlist Manager
Mckesson Corp Logo
Mckesson Corp
NYSE:MCK
Watchlist
Price: 808.62 USD -0.68% Market Closed
Market Cap: 99.8B USD

Mckesson Corp
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Mckesson Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Mckesson Corp
NYSE:MCK
Operating Income
$5.2B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
4%
Cardinal Health Inc
NYSE:CAH
Operating Income
$2.7B
CAGR 3-Years
20%
CAGR 5-Years
8%
CAGR 10-Years
1%
Henry Schein Inc
NASDAQ:HSIC
Operating Income
$769m
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
0%
Adapthealth Corp
NASDAQ:AHCO
Operating Income
$254.7m
CAGR 3-Years
5%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Patterson Companies Inc
NASDAQ:PDCO
Operating Income
$200.2m
CAGR 3-Years
18%
CAGR 5-Years
18%
CAGR 10-Years
-2%
Cencora Inc
NYSE:COR
Operating Income
$3.9B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
26%
No Stocks Found

Mckesson Corp
Glance View

McKesson Corporation, with its roots tracing back to 1833, stands as a healthcare titan in the pharmaceutical industry. Founded by John McKesson and Charles Olcott in New York City, the company began its journey as an importer and wholesaler of botanical drugs. McKesson has since evolved into one of the largest healthcare companies in the world, delivering critical logistics and distribution services that underpin the healthcare sector. The company's primary role is that of an intermediary, ensuring that pharmaceutical products and medical supplies make their way efficiently from manufacturers to pharmacies, hospitals, and clinics. This pivotal position places McKesson at the heart of the supply chain, making health products more accessible and affordable across North America and beyond. The operational mechanics of McKesson are a complex yet seamless orchestration of advanced logistics, technology, and customer service. By maintaining a vast network of distribution centers, the corporation processes and ships millions of pharmaceutical products daily, ensuring they are delivered within stringent timeframes. Through its well-oiled logistics system, McKesson earns its revenue mainly from the margins on product sales and the fees it charges for its distribution services. Furthermore, the company has diversified into additional areas like healthcare technology solutions, offering software and automation systems that aid healthcare providers in managing their operations more effectively. In summary, McKesson remains an indispensable player in healthcare, translating logistical prowess into a streamlined flow of pharmaceuticals from production to patient care.

MCK Intrinsic Value
1 284.92 USD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Mckesson Corp's Operating Income?
Operating Income
5.2B USD

Based on the financial report for Sep 30, 2025, Mckesson Corp's Operating Income amounts to 5.2B USD.

What is Mckesson Corp's Operating Income growth rate?
Operating Income CAGR 10Y
4%

Over the last year, the Operating Income growth was 18%. The average annual Operating Income growth rates for Mckesson Corp have been 16% over the past three years , 11% over the past five years , and 4% over the past ten years .

Back to Top